Biodesix (BDSX) Return on Capital Employed (2020 - 2026)

Biodesix (BDSX) has reported Return on Capital Employed for 7 consecutive years, with 32.57% the latest figure, recorded in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 32.57%, up 901.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 32.57% (up 901.0% YoY), and the FY2025 annual result was 37.2%, up 394.0% from the prior year.
• Return on Capital Employed was 32.57% for Q1 2026 at Biodesix, up from 39.44% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 32.57% in Q1 2026 and troughed at 152.13% in Q3 2022.
• Average Return on Capital Employed over 5 years is 73.29%, with a median of 58.12% recorded in 2024.
• Year-over-year, Return on Capital Employed slumped 11512 bps in 2022 and jumped 6155 bps in 2024.
• Over 5 years, Return on Capital Employed stood at 91.62% in 2022, then advanced by 24 bps to 69.45% in 2023, then surged by 42 bps to 40.27% in 2024, then advanced by 2 bps to 39.44% in 2025, then climbed by 17 bps to 32.57% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 32.57% in Q1 2026, 39.44% in Q4 2025, and 46.45% in Q3 2025.